Blog
Should Investors Worry About the Federal Investigation of Cassava?
Cassava Sciences (NASDAQ: SAVA) has been embroiled in a controversy for several months related to allegations that it falsified data for its experimental Alzheimer's disease drug simufilam. Last
Is Novavax's COVID Vaccine Authorization in the Philippines a Game-Changer?
Novavax (NASDAQ: NVAX) hasn't won authorization or approvals for its COVID-19 vaccine in major markets yet. However, the company did pick up an authorization in the Philippines last month. In this
How to Invest in Tesla for Less Than a Gallon of Gas
Depending where in the United States you live, a gallon of gas will now run you between around $3 and around $4.50 per gallon. While this is a high price compared with the recent past, it's still a
Down Big After Earnings, Is Lemonade a Buy Now?
Lemonade (NYSE: LMND) reported its latest results in early November, disappointing investors with its loss ratio and a surprising acquisition announcement. Since then, shares are down by nearly 30%
3 Hard Facts Moderna and Pfizer Investors Need to Know About the Omicron Variant
As the leading coronavirus vaccine makers in the U.S., Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) will once again be put to the test by a new viral variant. So far, the market hasn't reacted
Is AMC Entertainment Losing on the Big Screen With Its Latest Decline?
The recent slump in AMC Entertainment (NYSE: AMC) share value looks like potential bad news for the beleaguered theater chain. The latest superhero movie, Spider-Man: No Way Home, has sizzling
What Investors Need to Know About iBuying
You may have heard the term "iBuying" used when describing companies like Zillow (NASDAQ: ZG)(NASDAQ: Z) and Opendoor (NASDAQ: OPEN), but do you know what it really means? If not, we've got you
Despite Headwinds, SoFi's Q3 Earnings Were Impressive Across the Board
Many traditional banks lack the broad suite of services (and the velocity) that people demand in a digitally connected world. As a result, the financial services industry is becoming more
Splunk (SPLK) Q3 2022 Earnings Call Transcript
Image source: The Motley Fool.
Splunk (NASDAQ: SPLK)Q3 2022 Earnings CallDec 01, 2021, 4:30 p.m. ET
Operator
Source Fool.com
Are Bill.com and Lemonade Good Buys Now?
In this week's episode of Industry Focus: Financials, Fool.com contributor Matt Frankel, CFP® and host Jason Moser take a closer look at two stocks they bought last August, Lemonade (NYSE: LMND) and
Is Inovio Stock Set to Rebound?
Inovio Pharmaceuticals (NASDAQ: INO) has been one of the disappointments of the coronavirus vaccine race. Last year, the company fell behind in the development of its vaccine candidate. And this
Is Now the Right Time to Buy NovoCure?
NovoCure (NASDAQ: NVCR) was one of the better-performing stocks of early 2021, but the big gains came to an end in June. Since peaking this summer, shares have lost more than 58% of their value.
Is
1 Healthcare Stock I Plan to Own Forever
Healthpeak Properties (NYSE: PEAK) is a real estate investment trust, or REIT, that focuses on healthcare properties -- specifically life science, medical office, and senior housing. In this Fool
2 Growth Stocks Down Over 50% That Look Like Amazing Bargains
First off, the stock market isn't technically in a correction. Not yet, anyway. As of this writing, the S&P 500 is just 2.5% off its recent high, and the tech-heavy Nasdaq is down by less than 5%
Is Now Really the Time to Start Investing in the Stock Market?
Should you put your money in the stock market? This is a common question, especially in light of the economic volatility currently resulting from record-high inflation, a supply chain crisis, and
Why Rental Property Investing Is a Top Passive Income Strategy
Investing in real estate is one of the most powerful wealth-building tools. The great thing about it is that you do not have to be a millionaire to tap into the industry; any ordinary Joe or Jane
Why Moderna's Canada Booster Win Is Important
Many investors focus mainly on Moderna's (NASDAQ: MRNA) opportunities in the U.S. and Europe. However, the company markets its COVID-19 vaccine Spikevax in lots of other countries, notably including
This Terrific Opportunity Could Supercharge AMD Stock in the Long Run
Advanced Micro Devices (NASDAQ: AMD) is mostly known for supplying its chips to the personal computer (PC), data center, and gaming console markets, but the chipmaker is gaining traction in another
Why Is Everyone Talking About Twitter Stock?
Twitter's (NYSE: TWTR) stock took investors on a wild roller-coaster ride on Nov. 29 after CEO Jack Dorsey abruptly announced his resignation. Parag Agrawal, the company's chief technology officer
CarGurus Steps on the Gas After a Big Acquisition
Prior to the pandemic, CarGurus (NASDAQ: CARG) was making a name for itself as an online platform that connects automotive dealers and buyers. In 2019, the company grew revenue 30% and achieved a
Navigator Holdings (NVGS) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool.
Navigator Holdings (NYSE: NVGS)Q3 2021 Earnings CallNov 30, 2021, 10:00 a.m. ET
Operator
Source Fool.com
Could the Ethereum Upgrade Crush Cardano?
The cryptocurrency Ethereum (CRYPTO: ETH) has one big problem: transaction speed. The blockchain network processes fewer transactions per second than smaller, newer rival Cardano (CRYPTO: ADA). This
Here's Why Former Canopy Growth CEO Bruce Linton Thinks Cannabis Stocks Should Get Off the Major Exchanges
Many of the big cannabis companies that operate in Canada, where pot is legal federally, trade on a major exchange such as the Toronto Stock Exchange (TSX), the NASDAQ, or the New York Stock
The Smartest Stocks to Buy With $200 Right Now
Investors could get whiplash watching the stock market collapse last year, then quickly rebound to regain all the lost ground and go on to set new record highs.
It took the S&P 500 less than six
3 Stocks Cathie Wood Is Selling That Are Still Great Picks to Buy and Hold
Cathie Wood is a very good investor. That's evidenced by the fact that she runs two of the top three best-performing non-leveraged exchange-traded funds (ETFs) over the past five years. And another


